P. Aeruginosa Metabolites May Enable Better Patient Management

P. Aeruginosa Metabolites May Enable Better Patient Management

312278

P. Aeruginosa Metabolites May Enable Better Patient Management

Molecules produced by the environmental bacteria Pseudomonas aeruginosa, called alkyl-quinolones derivatives — which regulate bacterial gene activity and act in cell-to-cell communication — may be useful markers for better management of patients with cystic fibrosis (CF), a study suggests. These derivatives also may enable a more clear definition of the clinical stages of infection with the bacteria, known as P. aeruginosa, which is key in CF lung disease, the scientists said. Moreover, the team said,…

You must be logged in to read/download the full post.